Walleye Capital LLC Opti Nose, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$1.76 - $3.82 $63,757 - $138,383	36,226 New	36,226 $133,000
Q2 2021 Aug 16, 2021	SELL	$2.91 - $3.83 $794,042 - $1.05 Million	-272,867 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.47 - $4.75 $53,871 - $73,743	15,525 Added 6.03%	272,867 $1.01 Million
Q4 2020 Feb 16, 2021	SELL	$3.2 - $4.98 $136,505 - $212,436	-42,658 Reduced 14.22%	257,342 $1.07 Million
Q3 2020 Nov 16, 2020	BUY	$3.69 - $7.09 $1.11 Million - $2.13 Million	300,000 New	300,000 $1.17 Million

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $40M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.